sorafenib has been researched along with 3-hydroxybutyric acid in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (3-hydroxybutyric acid) | Trials (3-hydroxybutyric acid) | Recent Studies (post-2010) (3-hydroxybutyric acid) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 4,646 | 422 | 1,992 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, TL; Fang, CC; Liao, YJ; Suk, FM; Wu, CY | 1 |
1 other study(ies) available for sorafenib and 3-hydroxybutyric acid
| Article | Year |
|---|---|
β-HB treatment reverses sorafenib resistance by shifting glycolysis-lactate metabolism in HCC.
Topics: 3-Hydroxybutyric Acid; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Neoplasm; Glycolysis; Humans; Lactates; Liver Neoplasms; Sorafenib | 2023 |